| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.1 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |